Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Meda Oy
OY
Dissolved
Y-tunnus 0111457-9
Vaisalantie 4, 02130
Espoo
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1958
— employees
http://www.meda.fi
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Meda Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
9M
18M
28M
37M
30M
2018
31M
2019
30M
2020
32M
2021
EBITDA
EUR millions
0M
1M
1M
2M
2M
2M
2018
1M
2019
2M
2020
2M
2021
Income statement
EUR thousands
Item
2018
2019
2020
2021
Revenue
30 008
31 324
30 424
32 008
Staff expenses
−2 355
−2 202
−2 189
−1 250
EBITDA
1 698
1 218
1 607
1 684
Depreciation & amort.
−306
−295
−291
−280
EBIT
1 392
923
1 316
1 404
Net financials
−131
−118
−116
−133
Profit before tax
1 547
1 092
1 487
1 548
Tax
317
225
300
312
Net profit
1 230
867
1 186
1 236
Balance sheet
EUR thousands
Item
2018
2019
2020
2021
Total assets
17 843
15 935
17 973
18 642
Equity
5 273
5 910
6 868
7 883
Long-term debt
6 464
6 266
6 111
—
Short-term debt
6 106
3 756
4 995
10 759
Total debt
12 570
10 022
11 106
10 759
Financial ratios
5-year trend
EBITDA margin
5.3%
This company
15.8%
Market median
-66% vs market
2018
2021
Equity ratio
42.3%
This company
38.2%
Market median
+11% vs market
2018
2021
Return on equity
15.7%
This company
18.4%
Market median
+15% vs market
2018
2021
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
2018
2021
Asset turnover
1.72×
This company
1.12×
Market median
+54% vs market
2018
2021
Debt / equity
1.36×
This company
0.62×
Market median
-119% vs market
2018
2021
Annual reports & filings
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
View
PDF
More on Meda Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
